Measurment of lung diffusion capacity in patients with diabetes mellitus Source: Annual Congress 2009 - Impact on respiratory function of pulmonary and extrapulmonary diseases Year: 2009
Lung diffusion capacity variations in diabetes mellitus Source: Eur Respir J 2002; 20: Suppl. 38, 196s Year: 2002
Pulmonary microangiopathy as a possible complication in patients with diabetes mellitus Source: Eur Respir J 2004; 24: Suppl. 48, 222s Year: 2004
Study of PFT‘s in patients with type 2 diabetes mellitus and diabetic neuropathy and microangiopathy Source: Annual Congress 2007 - Lung function and therapy in obstructive lung diseases Year: 2007
The conjunctival microcirculation disturbances at COPD patients in combination with diabetes mellitus type 2 and their correction by gliclazide Source: Eur Respir J 2004; 24: Suppl. 48, 61s Year: 2004
Inadequate glucose control in type 2 diabetes is associated with impaired lung function and with systemic inflammation Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009
Are spirometry indices associated with microvascular complications in type 1 diabetes subjects? Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry Year: 2019
The association of pulmonary fibrosis with diabetes mellitus Source: ERJ Open Res, 6 (4) 00237-2020; 10.1183/23120541.00237-2020 Year: 2020
COPD prevalence and severity is associated to type 2 diabetes mellitus complications and lack of glycometabolic control Source: Annual Congress 2008 - COPD and comorbidities Year: 2008
Air-trapping and decreased diffusion capacity in patients with severe asthma Source: Annual Congress 2012 - Asthma: assessment and treatment Year: 2012
Relative risk of type 2 diabetes mellitus complications is increased in non effectively treated OSA patients Source: Eur Respir J 2005; 26: Suppl. 49, 39s Year: 2005
Changes in lung function in a rodent model of diabetes mellitus Source: International Congress 2018 – New methods and concepts in tests of lung and respiratory muscle function Year: 2018
Comparison of COPD patients with and without diabetes mellitus Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020
Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses Source: Eur Respir J 2013; 42: 1575-1585 Year: 2013
Elevated breath glucose is related to respiratory symptoms and not to disease type, control, duration or complications in diabetes mellitus patients Source: Eur Respir J 2007; 30: Suppl. 51, 365s Year: 2007
Baseline characteristics of idiopathic PAH patients with severely reduced diffusion capacity Source: Annual Congress 2012 - Pulmonary circulation: clinical databases and registries Year: 2012
Impact of pulmonary function on cardiovascular disease events in persons with metabolic syndrome and diabetes Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD Year: 2011
Particular feature of lungs microangiopathy in patients with tuberculosis and diabetes mellitus Source: Eur Respir J 2002; 20: Suppl. 38, 609s Year: 2002
Altered exercise capacity in children with type 1 diabetes Source: Virtual Congress 2021 – Respiratory physiology and breathing during sleep in health and sickness Year: 2021
Metformin predispose acute exacerbations of COPD patients with insulin-dependent diabetes mellitus> Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018